DAL International Announces September 1st Launch Date for Marketing the Balloon Weight Loss Procedure -- Will This Offer Turn the $46 Billion Weight Loss Industry Upside Down?

Market Wire, August, 2007

DAL International Ltd., (PINKSHEETS: DALN) announces today that its Medical Travel International Division will officially start offering the Balloon Weight Loss procedure to clients starting September 1, 2007.

Part of this launch will include a new BalloonWeightLoss.com informational website. Parties that are interested in getting more details about the Balloon Weight Loss Procedure can contact a MTI medical travel consultant at 800.501.0024.

The balloon weight loss procedure does not require an incision and is an outpatient procedure that takes on average 20 minutes to 1 hour to perform. The effectiveness of the balloon weight loss was evidenced at The 11th World Congress on Obesity Surgery held in Sydney, Australia in June of 2006, where published research abstracts verified the average weight loss was 70 pounds in six to eight months. This procedure has been proven safe and effective in international markets but is not yet FDA approved.

Medical Travel International provides its clients with access to international facilities that can perform this procedure at a fraction of the cost of gastric bypass and banding as well as provide after care medical support from its Network of U.S. Physicians. Trained medical travel consultants are available to walk the clients through the whole process.

CEO, Dr. Leatherman said the following, "We are excited to be able to offer the gastric balloon weight loss procedure. The balloon procedure has been proven safe, effective and affordable and does not require any incision like banding or gastric bypass. We believe this procedure offers real hope to the 127 million adult Americans that are overweight while offering them a proven and very powerful tool to retake control of their life. On average people lose up to 70 pounds within six months with the Balloon."

About DAL International

DAL International Ltd., is traded under the ticker symbol (PINKSHEETS: DALN) and is headquarted in Las Vegas, Nevada. DAL's mission is to become a leader within the medical travel and weight loss industry. This will be done by enhancing each client's quality of life through the combined use of medical expertise that delivers specialized, state-of-the-art, world class and affordable medical care and expanded treatment options through a Premier International network of physicians and hospitals that unite across national borders.

This press release contains forward-looking statements, which are made pursuant to the Safe Harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different. Factors include, but are not limited to, available funding, market acceptance, competition, recruitment and retention of personnel, dependence on key personnel and certain risks associated with the projects in which the Company is engaged to complete and others. The forward-looking statements should be considered in light of these risks and uncertainties. The Company disavows any obligation to update or correct any of its forward-looking statements.

For more information visit us online at www.DALLTD.com .

D. A. Leatherman, D.C. Phone: 1-800-501-0024 Fax: 1-760-328-5340 eMail: Email Contact